NasdaqGS:KRYSBiotechs
Assessing Krystal Biotech (KRYS) Valuation After Strong Recent Share Price Momentum
Krystal Biotech (KRYS) has drawn fresh attention after recent trading left the stock with a 1 day return of 3.35% and a past 3 months return of 48.25%, prompting investors to reassess its profile.
See our latest analysis for Krystal Biotech.
That move comes on top of a 13.3% 7 day share price return, an 18.2% 30 day share price return, and a 48.3% 90 day share price return. The 1 year total shareholder return of 94.7% and 3 year total shareholder return above 2.5x suggest strong momentum has...